These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20185255)

  • 1. Body iron stores and gender differences in risk factors for coronary heart disease.
    Mascitelli L; Pezzetta F; Goldstein MR
    Maturitas; 2010 May; 66(1):107. PubMed ID: 20185255
    [No Abstract]   [Full Text] [Related]  

  • 2. Gender differences in risk factors for coronary heart disease.
    Tan YY; Gast GC; van der Schouw YT
    Maturitas; 2010 Feb; 65(2):149-60. PubMed ID: 19897327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease.
    Ramsay JE; Stewart F; Greer IA; Sattar N
    BJOG; 2003 Nov; 110(11):1029-31. PubMed ID: 14592589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are body iron stores related to the risk of coronary heart disease?
    Ascherio A; Willett WC
    N Engl J Med; 1994 Apr; 330(16):1152-4. PubMed ID: 8133860
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
    Luque-Ramírez M; Alvarez-Blasco F; Botella-Carretero JI; Sanchón R; San Millán JL; Escobar-Morreale HF
    Diabetes Care; 2007 Sep; 30(9):2309-13. PubMed ID: 17536071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viewpoint: Gender differences in heart disease.
    Hensler P
    Circulation; 2006 Oct; 114(18):f170-1. PubMed ID: 17078127
    [No Abstract]   [Full Text] [Related]  

  • 7. Body iron stores and the risk of coronary heart disease.
    Giles WH; Anda RF; Williamson DF; Yip R; Marks J
    N Engl J Med; 1994 Oct; 331(17):1159-60. PubMed ID: 7935648
    [No Abstract]   [Full Text] [Related]  

  • 8. Explaining sex difference in coronary heart disease: is it time to shift from the oestrogen hypothesis to the iron hypothesis?
    Mascitelli L; Goldstein MR; Pezzetta F
    J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):64-5. PubMed ID: 21135587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.
    Talbott EO; Zborowskii JV; Boudraux MY
    Minerva Ginecol; 2004 Feb; 56(1):27-39. PubMed ID: 14973408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal gender and gestational-age-related incidence of pre-eclampsia.
    Elsmén E; Källén K; Marsál K; Hellström-Westas L
    Acta Obstet Gynecol Scand; 2006; 85(11):1285-91. PubMed ID: 17091404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.
    Boomsma CM; Eijkemans MJ; Hughes EG; Visser GH; Fauser BC; Macklon NS
    Hum Reprod Update; 2006; 12(6):673-83. PubMed ID: 16891296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are women with polycystic ovary syndrome (PCOS) at higher risk for development of Alzheimer disease?
    Sabayan B; Foroughinia F; Borhani Haghighi A; Mowla A
    Alzheimer Dis Assoc Disord; 2007; 21(3):265. PubMed ID: 17804962
    [No Abstract]   [Full Text] [Related]  

  • 13. Fertility in polycystic ovary syndrome.
    Patel SM; Nestler JE
    Endocrinol Metab Clin North Am; 2006 Mar; 35(1):137-55, vii. PubMed ID: 16310646
    [No Abstract]   [Full Text] [Related]  

  • 14. Body iron stores and the risk of coronary heart disease.
    Salonen JT; Nyyssönen K; Salonen R
    N Engl J Med; 1994 Oct; 331(17):1159; author reply 1160. PubMed ID: 7935647
    [No Abstract]   [Full Text] [Related]  

  • 15. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome.
    Glueck CJ; Bornovali S; Pranikoff J; Goldenberg N; Dharashivkar S; Wang P
    Diabet Med; 2004 Aug; 21(8):829-36. PubMed ID: 15270785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A woman's heart. An update of coronary artery disease risk in women.
    Leaf DA
    West J Med; 1988 Dec; 149(6):751-7. PubMed ID: 3074576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk in women with polycystic ovary syndrome.
    Orio F; Palomba S; Colao A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S20-1. PubMed ID: 16798279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.
    Glueck CJ; Goldenberg N; Pranikoff J; Loftspring M; Sieve L; Wang P
    Hum Reprod; 2004 Jun; 19(6):1323-30. PubMed ID: 15117896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polycystic ovarian syndrome and diabetes].
    Carlsen SM; Salvesen KA; Vanky E; Fougner KJ
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2619-21. PubMed ID: 16215603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.